Cargando…

STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS

Detalles Bibliográficos
Autores principales: Knight, Stacey, III, Russell R. Miller, Bair, Tami, Horne, Benjamin, Lopansri, Bert K., Anderson, Jeffrey, Muhlestein, J., Carlquist, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Cardiology Foundation. Published by Elsevier Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135612/
http://dx.doi.org/10.1016/S0735-1097(15)61444-9
_version_ 1783518095626731520
author Knight, Stacey
III, Russell R. Miller
Bair, Tami
Horne, Benjamin
Lopansri, Bert K.
Anderson, Jeffrey
Muhlestein, J.
Carlquist, John
author_facet Knight, Stacey
III, Russell R. Miller
Bair, Tami
Horne, Benjamin
Lopansri, Bert K.
Anderson, Jeffrey
Muhlestein, J.
Carlquist, John
author_sort Knight, Stacey
collection PubMed
description
format Online
Article
Text
id pubmed-7135612
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American College of Cardiology Foundation. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71356122020-04-08 STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS Knight, Stacey III, Russell R. Miller Bair, Tami Horne, Benjamin Lopansri, Bert K. Anderson, Jeffrey Muhlestein, J. Carlquist, John J Am Coll Cardiol Prevention American College of Cardiology Foundation. Published by Elsevier Inc. 2015-03-17 2015-03-16 /pmc/articles/PMC7135612/ http://dx.doi.org/10.1016/S0735-1097(15)61444-9 Text en Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Prevention
Knight, Stacey
III, Russell R. Miller
Bair, Tami
Horne, Benjamin
Lopansri, Bert K.
Anderson, Jeffrey
Muhlestein, J.
Carlquist, John
STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS
title STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS
title_full STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS
title_fullStr STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS
title_full_unstemmed STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS
title_short STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS
title_sort statin use at time of respiratory viral infection in patients with prior history of cardiovascular disease and risk of subsequent cardiovascular events
topic Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135612/
http://dx.doi.org/10.1016/S0735-1097(15)61444-9
work_keys_str_mv AT knightstacey statinuseattimeofrespiratoryviralinfectioninpatientswithpriorhistoryofcardiovasculardiseaseandriskofsubsequentcardiovascularevents
AT iiirussellrmiller statinuseattimeofrespiratoryviralinfectioninpatientswithpriorhistoryofcardiovasculardiseaseandriskofsubsequentcardiovascularevents
AT bairtami statinuseattimeofrespiratoryviralinfectioninpatientswithpriorhistoryofcardiovasculardiseaseandriskofsubsequentcardiovascularevents
AT hornebenjamin statinuseattimeofrespiratoryviralinfectioninpatientswithpriorhistoryofcardiovasculardiseaseandriskofsubsequentcardiovascularevents
AT lopansribertk statinuseattimeofrespiratoryviralinfectioninpatientswithpriorhistoryofcardiovasculardiseaseandriskofsubsequentcardiovascularevents
AT andersonjeffrey statinuseattimeofrespiratoryviralinfectioninpatientswithpriorhistoryofcardiovasculardiseaseandriskofsubsequentcardiovascularevents
AT muhlesteinj statinuseattimeofrespiratoryviralinfectioninpatientswithpriorhistoryofcardiovasculardiseaseandriskofsubsequentcardiovascularevents
AT carlquistjohn statinuseattimeofrespiratoryviralinfectioninpatientswithpriorhistoryofcardiovasculardiseaseandriskofsubsequentcardiovascularevents